BNP/CALL/EDWARDS LIFESCIENCES/110/0.1/19.12.25 | Market Closed - Börse Stuttgart 02:57:28 2024-07-03 EDT | ||
| 0.9 EUR | +1.12% |
|
| Current month | -11.76% | ||
| 1 month | +20.00% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-07-03 | 0.9 | +1.12% |
| 24-07-02 | 0.89 | -11.00% |
| 24-07-01 | 1 | -1.96% |
| 24-06-28 | 1.02 | +9.68% |
| 24-06-27 | 0.93 | +1.09% |
Delayed Quote Börse Stuttgart
Last update July 03, 2024 at 02:57 am
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
BNP Paribas
|
| WKN | PC610D |
| ISIN | DE000PC610D0 |
| Date issued | 2024-03-21 |
| Strike | 110 $ |
| Maturity | 2025-12-19 (534 Days) |
| Parity | 10 : 1 |
| Emission price | 1.03 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.3 € |
|---|---|
| Lowest since issue | 0.71 € |
| Spread | 0.09 € |
| Spread % | 9.09% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
91.08
USD
Average target price
96.13
USD
Spread / Average Target
+5.54%
- Stock Market
- Warrants
- Warrant
